Page last updated: 2024-11-04

rolipram and Osteosarcoma

rolipram has been researched along with Osteosarcoma in 1 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narita, M1
Murata, T1
Shimizu, K1
Sugiyama, T1
Nakagawa, T1
Manganiello, VC1
Tagawa, T1

Other Studies

1 other study available for rolipram and Osteosarcoma

ArticleYear
Phosphodiesterase 4 in osteoblastic osteosarcoma cells as a potential target for growth inhibition.
    Anti-cancer drugs, 2003, Volume: 14, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antineoplastic Agents; Bone Neoplasms; Cell Division; Cell Line

2003